Glaxo's Incruse Recommended For European Marketing Authorisation
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that Incruse, a treatment for chronic obstructive pulmonary disease, had been recommended for marketing authorisation by the European Medicines Agency's committee for Medical Products for Human Use, a key step in getting approval for the dr Read More